Human leukocyte antigen class i and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 2062-2070

  Lu, Yani ^a   Abdou, Amr M ^b   Cerhan, James R ^c   Morton, Lindsay M ^d   Severson, Richard K ^e   Davis, Scott ^f   Cozen, Wendy ^g   Rothman, Nathaniel ^d   Bernstein, Leslie ^a   Chanock, Stephen ^d   Hartge, Patricia ^d   Wang, Sophia S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Mayo Clinic College of Medicine   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

diffuse large B cell lymphoma; follicular lymphoma; human leukocyte antigen; survival; tumor necrosis factor

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADULT; AGED; ALLELE; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS;

EID: 81455132749     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2011/373876     Document Type: Article

References (12)

1. Gascoyne R. D., Emerging prognostic factors in diffuse large B cell lymphoma Current Opinion in Oncology 2004 16 5 436 441 (Pubitemid 39159170)
2. Solal-Céligny P., Roy P., Colombat P., White J., Armitage J. O., Arranz-Saez R., Au W. Y., Bellei M., Brice P., Caballero D., Coiffier B., Conde-Garcia E., Doyen C., Federico M., Fisher R. I., Garcia-Conde J. F., Guglielmi C., Hagenbeek A., Haoun C., LeBlanc M., Lister A. T., Lopez-Guillermo A., McLaughlin P., Milpied N., Morel P., Mounier N., Proctor S. J., Rohatiner A., Smith P., Soubeyran P., Tilly H., Vitolo U., Zinzani P. L., Zucca E., Montserrat E., Follicular lymphoma international prognostic index Blood 2004 104 5 1258 1265 (Pubitemid 39166497)
3. Abdou A. M., Gao X., Cozen W., Cerhan J. R., Rothman N., Martin M. P., Davis S., Schenk M., Chanock S. J., Hartge P., Carrington M., Wang S. S., Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma Leukemia 2010 24 5 1055 1058
4. Habermann T. M., Wang S. S., Maurer M. J., Morton L. M., Lynch C. F., Ansell S. M., Hartge P., Severson R. K., Rothman N., Davis S., Geyer S. M., Cozen W., Chanock S. J., Cerhan J. R., Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era Blood 2008 112 7 2694 2702
5. Juszczyski P., Kalinka E., Woszczek G., Borowiec M., Robak T., Kowalski M. L., Biliski P., Coiffiers B., Salles G., Warzocha K., The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas Przeglad Lekarski 2005 62 12 1417 1421
6. Kalinka E., Juszczyski P., Woszczek G., Borowiec M., Robak T., Kowalski M. L., Biliski P., Coiffier B., Salles G., Warzocha K., The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas Przeglad Lekarski 2005 62 12 1422 1426
7. Nowak J., Kalinka-Warzocha E., Juszczynski P., Bilinski P., Mika-Witkowska R., Zajko M., Bienvenu J., Coiffier B., Salles G., Warzocha K., Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma Genes Chromosomes and Cancer 2007 46 5 500 507 (Pubitemid 46449253)
8. Wang S. S., Abdou A. M., Morton L. M., Thomas R., Cerhan J. R., Gao X., Cozen W., Rothman N., Davis S., Severson R. K., Bernstein L., Hartge P., Carrington M., Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology Blood 2010 115 23 4820 4823
9. Conde L., Halperin E., Akers N. K., Brown K. M., Smedby K. E., Rothman N., Nieters A., Slager S. L., Brooks-Wilson A., Agana L., Riby J., Liu J., Adami H. O., Darabi H., Hjalgrim H., Low H. Q., Humphreys K., Melbye M., Chang E. T., Glimelius B., Cozen W., Davis S., Hartge P., Morton L. M., Schenk M., Wang S. S., Armstrong B., Kricker A., Milliken S., Purdue M. P., Vajdic C. M., Boyle P., Lan Q., Zahm S. H., Zhang Y., Zheng T., Becker N., Benavente Y., Boffetta P., Brennan P., Butterbach K., Cocco P., Foretova L., Maynadié M., De Sanjosé S., Staines A., Spinelli J. J., Achenbach S. J., Call T. G., Camp N. J., Glenn M., Caporaso N. E., Cerhan J. R., Cunningham J. M., Goldin L. R., Hanson C. A., Kay N. E., Lanasa M. C., Leis J. F., Marti G. E., Rabe K. G., Rassenti L. Z., Spector L. G., Strom S. S., Vachon C. M., Weinberg J. B., Holly E. A., Chanock S., Smith M. T., Bracci P. M., Skibola C. F., Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32 Nature Genetics 2010 42 8 661 664
10. Martin M. P., Gao X., Lee J. H., Nelson G. W., Detels R., Goedert J. J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S. J., Carrington M., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nature Genetics 2002 31 4 429 434 (Pubitemid 35154456)
11. Cerhan J. R., Wang S., Maurer M. J., Ansell S. M., Geyer S. M., Cozen W., Morton L. M., Davis S., Severson R. K., Rothman N., Lynch C. F., Wacholder S., Chanock S. J., Habermann T. M., Hartge P., Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival Blood 2007 109 12 5439 5446 (Pubitemid 46890567)
12. Lech-Maranda E., Bienvenu J., Broussais-Guillaumot F., Warzocha K., Michallet A. S., Robak T., Coiffier B., Salles G., Plasma TNF- and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index Archivum Immunologiae et Therapiae Experimentalis 2010 58 2 131 141